Umbilical cord blood transplantation: the first 25 years and beyond
KK Ballen, E Gluckman… - Blood, The Journal of the …, 2013 - ashpublications.org
Umbilical cord blood is an alternative hematopoietic stem cell source for patients with
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …
hematologic diseases who can be cured by allogeneic hematopoietic cell transplantation …
[HTML][HTML] Optimal practices in unrelated donor cord blood transplantation for hematologic malignancies
JN Barker, J Kurtzberg, K Ballen, M Boo… - Biology of Blood and …, 2017 - Elsevier
Unrelated donor cord blood transplantation (CBT) results in disease-free survival
comparable to that of unrelated adult donor transplantation in patients with hematologic …
comparable to that of unrelated adult donor transplantation in patients with hematologic …
[HTML][HTML] Unmanipulated haploidentical bone marrow transplantation and posttransplantation cyclophosphamide for hematologic malignancies after myeloablative …
AM Raiola, A Dominietto, A Ghiso, C Di Grazia… - Biology of Blood and …, 2013 - Elsevier
Fifty patients with high-risk hematologic malignancies, underwent an unmanipulated
haploidentical bone marrow transplantation (BMT), followed by posttransplantation high …
haploidentical bone marrow transplantation (BMT), followed by posttransplantation high …
[HTML][HTML] Unmanipulated haploidentical transplants compared with other alternative donors and matched sibling grafts
AM Raiola, A Dominietto, C di Grazia… - Biology of Blood and …, 2014 - Elsevier
We studied 459 consecutive patients with hematologic malignancies, median age 44 years
(range, 15 to 71 years), who underwent transplantation with grafts from identical sibling …
(range, 15 to 71 years), who underwent transplantation with grafts from identical sibling …
Haploidentical, unmanipulated, G-CSF–primed bone marrow transplantation for patients with high-risk hematologic malignancies
P Di Bartolomeo, S Santarone… - Blood, The Journal …, 2013 - ashpublications.org
Eighty patients with high-risk hematologic malignancies underwent unmanipulated, G-CSF–
primed BM transplantation from an haploidentical family donor. Patients were transplanted …
primed BM transplantation from an haploidentical family donor. Patients were transplanted …
In vivo DPP-4 inhibition to enhance engraftment of single-unit cord blood transplants in adults with hematological malignancies
Delayed engraftment is a significant limitation of umbilical cord blood (UCB) transplantation
due to low stem cell numbers. Inhibition of dipeptidyl peptidase (DPP)-4 enhanced …
due to low stem cell numbers. Inhibition of dipeptidyl peptidase (DPP)-4 enhanced …
Comparison of outcomes after single or double cord blood transplantation in adults with acute leukemia using different types of myeloablative conditioning regimen, a …
We report outcomes after single (s) and double (d) umbilical cord blood transplantation
(UCBT) after myeloablative conditioning (MAC) regimen for 239 patients transplanted for …
(UCBT) after myeloablative conditioning (MAC) regimen for 239 patients transplanted for …
Thiotepa, busulfan, and fludarabine conditioning regimen in T cell-replete HLA-haploidentical hematopoietic stem cell transplantation
We report the outcomes of 51 patients who underwent unmanipulated haploidentical
hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation …
hematopoietic stem cell transplantation (haplo-HSCT) with post-transplantation …
Impact of ATG-containing reduced-intensity conditioning after single-or double-unit allogeneic cord blood transplantation
L Pascal, L Tucunduva, A Ruggeri… - Blood, The Journal …, 2015 - ashpublications.org
We analyzed 661 adult patients who underwent single-unit (n= 226) or double-unit (n= 435)
unrelated cord blood transplantation (UCBT) following a reduced-intensity conditioning …
unrelated cord blood transplantation (UCBT) following a reduced-intensity conditioning …
Haploidentical transplantation is associated with better overall survival when compared to single cord blood transplantation: an EBMT-Eurocord study of acute …
Background Thiotepa-busulfan-fludarabine (TBF) is a widely used conditioning regimen in
single umbilical cord blood transplantation (SUCBT). More recently, it was introduced in the …
single umbilical cord blood transplantation (SUCBT). More recently, it was introduced in the …